CClinicalTrials.gg
RecruitingNCT07785635Updated Aug 25, 2026

Evaluation of the Relation Between Patient Fasting Time and the Occurrence of PIH (Post Induction Hypotension)

An observational study in Post-induction Hypotension, sponsored by University Hospital Ostrava. Recruiting at 1 site in Czechia. Open to participants aged 18 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-08-25.

Sponsored by University Hospital Ostrava · Observational

Study type
Observational
Model
Case-control
Time perspective
Prospective
Enrollment
100
Ages
18 Years and older
Sex
All
01

Study summary

This monocentre prospective trial aims to evaluate the relationship between fasting time and the occurence of PIH (post-induction hypotension).

Read the detailed description

A decrease in blood pressure (BP) after induction of general anesthesia (GA) is a common phenomenon. The etiology is multifactorial (vasodilatory and dále negative inotropic effects of anaesthetics, reduction in sympathetic tone, the effect of positive pressure ventilation and others). Relative hypovolemia due to patient fasting is one of the factors that can have a significant influence on the decrease in blood pressure after induction of GA. Different lengths of fasting may thus lead to variations in both the incidence of hypotension after induction of GA (post-induction hypotension - PIH) and the severity of the BP drop.

02

Conditions studied

  • Post-induction Hypotension

Browse trials for

Keywords

  • General anaesthesia
  • Post-induction hypotension
  • Fasting
  • Decrease of blood pressure
03

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
Yes
Sampling method
Non-probability sample

Study population

Patients undergoing surgery in general anaesthesia

Inclusion criteria

  • Age ≥ 18 years
  • Patients undergoing planned surgical or diagnostic procedure
  • Intubation under general anaesthesia

Exclusion criteria

Exclusion Criteria:

  • Pregnancy
  • Disagreement with participation in the study
  • Bowel preparation
04

Study design

Observational model
Case-control
Time perspective
Prospective
Enrollment
100 participants (estimated)
Patient registry
No
05

What researchers measure

Primary outcomes

  1. Post induction hypotension (PIH)

    The incidence of the post induction hypotension (PIH) will be assessed in the study subjects.

    Time frame: 1 month

  2. Seriousness of post induction hypotension (PIH)

    Seriousness of post induction hypotension (PIH) will be assessed to determine whether patients with longer fasting time experience a significant reduction of blood pressure after induction of general anaesthesia.

    Time frame: 1 month

  3. Comparison of other PIH risk factors

    The risk factors such as comordibity, chronic medication, type and doses of induction drugs will be compared.

    Time frame: 1 month

06

Study locations

1 of 1 sites recruiting
  • University Hospital Ostrava
    Ostrava, Moravian-Silesian Region 70852, Czechia
    • Jiří Hynčica · Contact · jiri.hyncica@fno.cz · 0042059737
    • Ondřej Jor, MD, PhD, MBA · Principal investigator
    • Alexandra Skácelíková, BSc · Sub investigator
    Recruiting
07

References and documents

Publications

  • Sudfeld S, Brechnitz S, Wagner JY, Reese PC, Pinnschmidt HO, Reuter DA, Saugel B. Post-induction hypotension and early intraoperative hypotension associated with general anaesthesia. Br J Anaesth. 2017 Jul 1;119(1):57-64. doi: 10.1093/bja/aex127. PubMed 28974066 ↗

Individual participant data

Plan to share: No — There is no plan to make individual participant data available to other researchers. The data may be provided upon request.

08

Registry details

Key details

Study ID
NCT07785635
Lead sponsor
University Hospital Ostrava
Responsible party
Sponsor
First posted
Aug 25, 2026
Start date
May 1, 2025
Primary completion
Sep 2026 (estimated)
Completion
Sep 2026 (estimated)
Last update
Aug 25, 2026

Study contacts

Jiří Hynčica
Contact
jiri.hyncica@fno.cz
0042059737 ext. 2587
Ondřej Jor, MD, PhD, MBA
principal investigator · University Hospital Ostrava

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion